You searched for "outcomes"

1708 results found

Cataract surgery in uveitis patients

Cataract formation is a common complication of uveitis, causing up to 40% of vision loss in these patients. Cataract results from inflammation +/- corticosteroid therapy and is usually posterior subcapsular, but a small proportion have a rapid increase in nuclear...

Discussing treatment modalities for bilateral wet AMD

A 65-year-old lady with bilateral wet AMD and vision of 6/24 comes with an internet search about current therapies. How do you explain the various treatment modalities available? There are two NICE approved treatments for wet age-related macular degeneration (AMD)....

IN FOCUS - Prevention and treatment of blindness worldwide: the story of ‘VISION 2020: The Right to Sight’

The story of blindness and efforts to prevent and treat it cannot be told without going back to the earliest recorded history of blindness. Trachoma was described in ancient Egypt, cataract surgery in India about the fifth century BC and...

Building research capacity through the VISION 2020 LINKS Programme

The aim is to build capacity for research in the region covered by the College of Ophthalmology of Eastern, Central and Southern Africa (COECSA). The project will build research capacity in three ophthalmology training institutions by ‘training the trainers’ and...

The role of spectral-domain OCT RNFL in revealing a pituitary adenoma with atypical visual fields

Pituitary adenomas classically cause bitemporal hemianopia by compressing the optic chiasm. However, in some cases, the pattern of visual field loss may be atypical and mimic homonymous hemianopia, depending on the direction and extent of tumour expansion. Spectral-domain optical coherence...

Features from screening programme referrals pre and post pandemic

In this study the authors conducted an analysis of demographics, referral rates and prevalence of various ophthalmic assessments among children referred to an ophthalmologist through the UCI eye mobile programme. They further evaluated the influence of socio-economic factors and the...

RNIB's verdict on the 10-Year Plan for the NHS

The UK Government has released the long awaited 10-Year Plan to reform the National Health Service (NHS) in England. The Plan outlines the details and proposals to deliver on the promised three changes which would transform healthcare across the country:...

An update on idiopathic intracranial hypertension

The incidence of Idiopathic intracranial hypertension (IIH) is increasing, likely in line with the worldwide epidemic of obesity. To date, there have been revisions in the terminology used and diagnostic criteria for IIH; these recognise the need to exclude secondary...

Eyecare challenges in the Middle East: Priorities of a global ophthalmology task force

Global ophthalmology is a rapidly evolving, multidisciplinary field that integrates clinical practice, research, and policy at national and international levels. One of its main objectives is to improve eyecare equity worldwide by preventing avoidable vision impairment. Since the launch of...

Report on preoperative visual acuities of patients from two AMM surgical trips to Magdalena, Northern Bolivia

The Andean Medical Mission (AMM), founded in 2012, recently celebrated 12 years of dedicated service in the Bolivian Amazon, aiming to eliminate avoidable blindness. Over this period, AMM has successfully performed over 1700 surgeries, including for children with congenital or...

Using medical AI as ‘autopilot’ risks deskilling of clinicians, caution doctors and aviation safety experts

As artificial intelligence (AI) becomes increasingly integrated into healthcare services, there are important lessons that the medical profession can learn from the aviation industry, which faced widespread loss of human skills after the adoption of autopilot. While calls for medicine...

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.